micronized progesterone oral
Selected indexed studies
- Diagnostic and therapeutic use of oral micronized progesterone in endocrinology. (Rev Endocr Metab Disord, 2024) [PMID:38652231]
- Oral micronized progesterone. (Clin Ther, 1999) [PMID:10090424]
- Oral dydrogesterone versus micronized vaginal progesterone for luteal phase support: a double-blind crossover study investigating pharmacokinetics and impact on the endometrium. (Hum Reprod, 2024) [PMID:38110714]
_Worker-drafted node — pending editorial review._
Connections
micronized progesterone oral is a side effect of
Sources
- Diagnostic and therapeutic use of oral micronized progesterone in endocrinology. (2024) pubmed
- Oral micronized progesterone. (1999) pubmed
- Oral dydrogesterone versus micronized vaginal progesterone for luteal phase support: a double-blind crossover study investigating pharmacokinetics and impact on the endometrium. (2024) pubmed
- The impact of micronized progesterone on the endometrium: a systematic review. (2016) pubmed
- Oral micronized progesterone versus vaginal progesterone for luteal phase support in fresh embryo transfer cycles: a multicenter, randomized, non-inferiority trial. (2023) pubmed
- The impact of micronized progesterone on breast cancer risk: a systematic review. (2018) pubmed
- Oral micronized progesterone. Bioavailability pharmacokinetics, pharmacological and therapeutic implications--a review. (1987) pubmed
- Oral dydrogesterone along with vaginal micronized progesterone supplementation for luteal phase support in IVF patients, and its impact on pregnancy and live birth rates: a prospective randomized trial. (2024) pubmed
- Oral micronized progesterone for perimenopausal night sweats and hot flushes a Phase III Canada-wide randomized placebo-controlled 4 month trial. (2023) pubmed
- Oral dydrogesterone versus oral micronized progesterone in threatened miscarriage: protocol paper for a randomized controlled trial. (2025) pubmed